News 2022-01-19 NGeneBio at MEDLAB ME 2022 NGeneBio is going to participate in MEDLAB Middle East 2022, the world's largest medical laboratory… haeryeong hong Love0
News 2021-12-31 Quarterly Newsletter_4Q 2021 Full text: https://us1.campaign-archive.com/?u=fdd105924b8a2d905af7088f0&id=e48a673a7c haeryeong hong Love0
Press Center 2021-12-12 [KR] NGeneBio held the first press conference NGeneBio held the first domestic press conference for the medical journalists and ended in great… haeryeong hong Love0
Press Center 2021-11-25 NGeneBio Gets CE-IVD Mark for HLA Typing Assay NEW YORK — South Korean diagnostics firm NGeneBio said on Tuesday that it has received… haeryeong hong Love0
News 2021-11-19 NGeneBio at MEDICA 2021 NGeneBio participates in MEDICA 2021, which will be held in Atlanta on 15-18 November at… haeryeong hong Love0
News 2021-10-15 NGeneBio nominated for the Best oral/poster award at LMCE 2021 NGeneBio participated as an exhibitionist at the International Conference of the Korean Society for Laboratory… haeryeong hong Love0
News 2021-09-29 Quarterly Newsletter_3Q 2021 Full view via link: https://mailchi.mp/c41202da2377/ngenebio-quarterly-newsletter-2q-4587706 haeryeong hong Love0
Press Center 2021-09-08 [KR] NGeneBio and CNUHH will build a cloud-based genome analysis platform NGeneBio has signed a service contract with Chonnam National University Hwasun Hospital(CNUHH) to build a… haeryeong hong Love0
News 2021-08-27 NGeneBio at AACC 2021 NGeneBio is going to participate in AACC 2021, which will be held in Atlanta on… haeryeong hong Love0
Press Center 2021-08-23 [KR] NGeneBio gained approval ‘BRCAaccuTEST PLUS’ from KFDA NGeneBio’s genetic testing products for BRCA1 and BRCA2 mutations gained approval from Korea MFDS (Ministry… haeryeong hong Love0